This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
{
"resourceType" : "ValueSet",
"id" : "mcode-histology-morphology-behavior-vs",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Include all codes defined in <a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-icd-o-3.html\"><code>http://terminology.hl7.org/CodeSystem/icd-o-3</code></a></li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 367651003 (Malignant Neoplasm (Morphology))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))</li><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://snomed.info/id/399878004\">399878004</a></td><td>Malignant neoplasm with pilar differentiation (morphologic abnormality)</td></tr><tr><td><a href=\"http://snomed.info/id/253035009\">253035009</a></td><td>In situ melanocytic morphology (morphologic abnormality)</td></tr></table></li></ul><p>This value set excludes codes based on the following rules:</p><ul><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 703548001 (Atypical hyperplasia of the endometrium)</li></ul></div>"
},
"url" : "http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs",
"version" : "2.0.0",
"name" : "HistologyMorphologyBehaviorVS",
"title" : "Histology Morphology Behavior Value Set",
"status" : "active",
"date" : "2022-01-18T03:17:40+00:00",
"publisher" : "HL7 International Clinical Interoperability Council",
"contact" : [
{
"name" : "HL7 International Clinical Interoperability Council",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/cic"
},
{
"system" : "email",
"value" : "ciclist@lists.HL7.org"
}
]
}
],
"description" : "Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: ICD-O-3 morphology codes are referenced in the logical definition but not expanded in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
]
}
],
"copyright" : "This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement",
"compose" : {
"include" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/icd-o-3"
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "367651003"
}
]
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "399919001"
}
]
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "399983006"
}
]
},
{
"system" : "http://snomed.info/sct",
"concept" : [
{
"code" : "399878004",
"display" : "Malignant neoplasm with pilar differentiation (morphologic abnormality)"
},
{
"code" : "253035009",
"display" : "In situ melanocytic morphology (morphologic abnormality)"
}
]
}
],
"exclude" : [
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "450893003"
}
]
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "128640002"
}
]
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "450890000"
}
]
},
{
"system" : "http://snomed.info/sct",
"filter" : [
{
"property" : "concept",
"op" : "is-a",
"value" : "703548001"
}
]
}
]
}
}